Orthox to Commence Trial of FibroFix Knee Cartilage Repair
Orthox received permission in the UK to begin the "FFLEX Study" (derived from the "FibroFix cartiLage repair Experience")....
Jul 13, 2022,
Orthobiologics
ORTHOFLASH 
AlloSource Launches AlloFuse Micro Fiber Allograft
AlloFuse Micro Fibers are the latest addition to the AlloFuse line of Fibers and Fiber Boat products, expanding the company's...
Jun 29, 2022,
Isto Biologics Launches Influx Fibrant Allograft
Influx Fibrant cortical allograft constructs are available in Anchor, Boat, Bullet, Pak and Wrap formats....
Jun 22, 2022,
Theradaptive Secures Third FDA Breakthrough Designation
FDA granted Breakthrough Medical Device designation for the use of OsteoAdapt SP in Anterior Lumbar Interbody Fusion....
Jun 22, 2022,
Graftys Granted Patent for CPC Mixed with Blood
Based on blood clotting processing, this new macroporous calcium phosphate cement is designed to stimulate bone regeneration....
Jun 13, 2022,
First 100 Patients in the U.S. Treated with OssDsign Catalyst
The synthetic bone graft was launched in the U.S. in 2021, and has since been adopted by surgeons for use...
Jun 13, 2022,
Lipogems To Launch Study to Treat Knee Osteoarthritis
Lipogems will conduct an IDE study for treatment of knee osteoarthritis compared to corticosteroids for a period of 12 months....
Jun 10, 2022,
Royal Biologics Launches MAXX-BMC Bone Marrow Aspirate Concentration System
Maxx-BMC's Lead Screw technology helps pinpoint precise areas of the growth factor layer of bone marrow aspirate in a matter...
Jun 01, 2022,
Kuros MagnetOs: First Trial Results
Kuros Biosciences announces favorable preliminary results for MagnetOs as standalone alternative to autograft in its first randomized controlled trial....
May 31, 2022,
FDA Market Authorization for BONESUPPORT’s CERAMENT G
FDA granted market authorization for the antibiotic eluting product CERAMENT G, for the indication bone infection (osteomyelitis)....
May 25, 2022,
Loading new posts...
No more posts
